Chronic bee paralysis virus exploits host antimicrobial peptides and alters gut microbiota composition to facilitate viral infection
The ISME Journal · 08.01.2024 · 18 (1)
DOI: 10.1093/ismejo/wrae051 ↗Kurz gefasst
Fachartikel in der Zeitschrift The ISME Journal, online erschienen am 22.03.2024. Verfasst von Yanchun Deng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bast Fiber Crops, Chinese Academy of Agricultural Sciences, Changsha 410205, China. Hauptthemen laut MEDLINE: RNA Viruses, Gastrointestinal Microbiome, Insect Viruses, Viruses. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Agricultural Science, Technology Innovation Program of CAAS, Central Public-interest Scientific Institution Basal Research Fund.
Abstract (Originalsprache)
The significance of gut microbiota in regulating animal immune response to viral infection is increasingly recognized. However, how chronic bee paralysis virus (CBPV) exploits host immune to disturb microbiota for its proliferation remains elusive. Through histopathological examination, we discovered that the hindgut harbored the highest level of CBPV, and displayed visible signs of damages. The metagenomic analysis showed that a notable reduction in the levels of Snodgrassella alvi and Lactobacillus apis, and a significant increase in the abundance of the opportunistic pathogens such as Enterobacter hormaechei and Enterobacter cloacae following CBPV infection. Subsequent co-inoculation experiments showed that these opportunistic pathogens facilitated the CBPV proliferation, leading to accelerated mortality in bees and exacerbation of bloated abdomen symptoms after CBPV infection. The expression level of antimicrobial peptide (AMP) was found to be significantly up-regulated by over 1000 times in response to CBPV infection, as demonstrated by subsequent transcriptome and quantitative real-time PCR investigations. In particular, through correlation analysis and a bacteriostatic test revealed that the AMPs did not exhibit any inhibitory effect against the two opportunistic pathogens. However, they did demonstrate inhibitory activity against S. alvi and L. apis. Our findings provide different evidence that the virus infection may stimulate and utilize the host’s AMPs to eradicate probiotic species and facilitate the proliferation of opportunistic bacteria. This process weakens the intestinal barrier and ultimately resulting in the typical bloated abdomen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Bast Fiber Crops, Chinese Academy of Agricultural Sciences, Changsha 410205, China.
- Institute of Apicultural Research, Chinese Academy of Agricultural Sciences, Beijing 100193, China.
- Graduate School of Chinese Academy of Agricultural Sciences, Beijing 100081, China.
Förderung
- National Natural Science Foundation of China
- Agricultural Science, Technology Innovation Program of CAAS
- Central Public-interest Scientific Institution Basal Research Fund
Zitieren
APA
Deng, Y., Yang, S., Zhang, L., Chen, C., Cheng, X., & Hou, C. (2024). Chronic bee paralysis virus exploits host antimicrobial peptides and alters gut microbiota composition to facilitate viral infection. The ISME Journal, 18(1). https://doi.org/10.1093/ismejo/wrae051
Vancouver
Deng Y, Yang S, Zhang L, Chen C, Cheng X, Hou C. Chronic bee paralysis virus exploits host antimicrobial peptides and alters gut microbiota composition to facilitate viral infection. The ISME Journal. 2024;18(1). doi:10.1093/ismejo/wrae051
BibTeX
@article{Deng2024,
author = {Deng, Yanchun and Yang, Sa and Zhang, Li and Chen, Chenxiao and Cheng, Xuefen and Hou, Chunsheng},
title = {Chronic bee paralysis virus exploits host antimicrobial peptides and alters gut microbiota composition to facilitate viral infection},
journal = {The ISME Journal},
year = {2024},
volume = {18},
number = {1},
doi = {10.1093/ismejo/wrae051}
}
EUVIMED